Global Protein Labelling Market, By Labelling Method (In Vitro Labelling, In Vivo Labelling and Biorthogonal Labelling), Product (Reagents, Kits and Services), Application (Immunological Techniques, Cell-Based Assays, Fluorescence Microscopy, Protein Microarrays and Mass Spectrometry), End User (Hospitals, Academic Institutes, Research Laboratories and Diagnostic Centres), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Protein Labelling Market
Data Bridge Market Research analyses that the protein labelling market to growing at a CAGR of 9.90% in the forecast period of 2022-2029.
Protein labelling is a process in which molecular labels are covalently attached to the desired protein molecule to facilitate the detection and purification of the labelled protein and its binding associates. This technique employs molecular labels that covalently attach to various protein molecules such as biotin, enzymes, fluorophores, and radioactive isotopes to the desired protein target.
Rising healthcare spending and interest in proteomics research are expected to drive the protein labelling market in the coming years. Furthermore, technological advancements in this segment, as well as rising research and development spending, are expected to boost the market in the coming years. Furthermore, advancements in mass spectrometry workflows and biochip miniaturisation are expected to drive the market during the forecasted period.
Growth in healthcare expenditure, rising levels of investment for the expansion of advanced technology, an ageing population, and positive government policies pertaining to protein identification are expected to accelerate the growth of the protein labelling market during the forecast period of 2022-2029.
However, the lacks of skilled professionals, as well as competition among major players, are likely to hinder the growth of the protein labelling market during the forecast period.
This protein labelling market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on protein labelling market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Protein Labelling Market Scope and Market Size
Protein labelling market is segmented on the basis of labelling method, product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on labelling method, the protein labelling market is segmented into in vitro Labelling, in vivo labelling and bioorthogonal Labelling. The in vitro Labelling segment is further sub-segmented on the basis of Labelling method into enzymatic Labelling, dye-based Labelling, cotranslational Labelling, site-specific Labelling, and nanoparticle Labelling. The in vivo Labelling segment is further sub-segmented on the basis of Labelling method into photoreactive Labelling and radioactive Labelling.
- Based on product, the global protein labelling market is segmented into reagents, kits and services segments. The reagents segment is further sub-segmented on the basis of product into enzymes, monoclonal antibodies, proteins, probes/tags, and other reagents.
- On the basis of application, the global protein labelling market is classified into immunological techniques, cell-based assays, fluorescence microscopy, protein microarrays, and mass spectrometry.
- Protein labelling market has also been segmented based on the end user into hospitals, academic institutes, research laboratories and diagnostic centers.
Protein Labelling Market Country Level Analysis
The protein labelling market is analysed and market size insights and trends are provided by country, labelling method, product, application and end user as referenced above.
The countries covered in the protein labelling market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the protein labelling market due to the presence of major players in the region working on improving their portfolios and offerings, as well as the rise in acceptance of protein labelling in tandem with the expansion of genomic sequencing and personalised medicine, which are the major factors driving the region's dominant position, whereas Asia-Pacific is expected to grow at the fastest rate during the forecast period of 2022 to 2029 due to higher healthcare spending.
The country section of the protein labelling market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The protein labelling market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for protein labelling market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the protein labelling market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Protein Labelling Market Share Analysis
The protein labelling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to protein labelling market.
Some of the major players operating in the protein labelling market are Thermo Fisher Scientific, Inc., Merck KGaA, Perkinelmer, Inc., F. Hoffman-La Roche AG, General Electric Company, Kaneka Corporation, Li-Cor, Inc., Promega Corporation, New England Biolabs, Seracare Life Sciences, Inc., Luminex Corporation, Active Motif, Inc., Takara Bio USA, Inc., Candor Bioscience GMBH, Innova Biosciences Ltd., Biotium, Inc., Qiagen N.V., Agilent Technologies, Inc., Caprion Biosciences, Nanotemper Technologies GMBH, Bio-Rad Laboratories, Bruker Inc., Kirkegaard & Perry Laboratories, Eurogentec S.A, B. Braun Melsungen AG, and Ethicon, Inc. among others.